Rockefeller Capital Management L.P. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 218 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$344,154
-45.4%
42,912
+0.8%
0.00%
-50.0%
Q1 2024$630,606
+94.5%
42,551
+6.7%
0.00%
+100.0%
Q4 2023$324,167
+22.0%
39,873
+5.6%
0.00%0.0%
Q2 2023$265,816
+120178.7%
37,758
+3.8%
0.00%0.0%
Q1 2023$221
+0.9%
36,373
+5.8%
0.00%0.0%
Q4 2022$219
-99.9%
34,373
+11.3%
0.00%
-50.0%
Q3 2022$295,000
-15.0%
30,873
-2.2%
0.00%0.0%
Q2 2022$347,000
-8.0%
31,555
+39.1%
0.00%0.0%
Q1 2022$377,000
-13.9%
22,684
-1.3%
0.00%0.0%
Q4 2021$438,000
+5375.0%
22,992
+6469.1%
0.00%
Q3 2021$8,000
-38.5%
350
-30.0%
0.00%
Q2 2021$13,000
-13.3%
5000.0%0.00%
Q1 2021$15,000
-34.8%
5000.0%0.00%
Q4 2020$23,000
-23.3%
500
-45.2%
0.00%
Q3 2020$30,000
+25.0%
912
+5.7%
0.00%
Q2 2020$24,000
-14.3%
863
-7.2%
0.00%
Q1 2020$28,000
+33.3%
930
+24.0%
0.00%
Q4 2019$21,000
+2000.0%
750
+814.6%
0.00%
Q1 2019$1,000820.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,019,201$26,720,00020.38%
Broadfin Capital, LLC 5,951,153$52,668,0006.92%
GREAT POINT PARTNERS LLC 5,567,348$49,271,0006.23%
Avoro Capital Advisors LLC 10,261,039$90,810,0005.43%
FRAZIER MANAGEMENT LLC 2,188,331$19,367,0005.00%
Prosight Management, LP 1,062,500$9,403,0004.85%
Perceptive Advisors 12,241,111$108,333,0004.12%
Ghost Tree Capital, LLC 1,000,000$8,850,0003.21%
QVT Financial LP 1,021,361$8,696,0002.84%
Vivo Capital, LLC 1,600,000$14,160,0001.81%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders